putrescine has been researched along with dinoprostone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Prosser, FH; Wahl, LM | 1 |
Bansard, JY; Catros-Quemener, V; Chamaillard, L; Commeurec, A; Delcros, JG; Desury, D; Genetet, N; Havouis, R; Moulinoux, JP | 1 |
Bozza, PT; Castro-Faria-Neto, HC; de Mello, FG; DosReis, GA; Freire-de-Lima, CG; Lopes, MF; Nascimento, DO; Soares, MB | 1 |
Nicocia, G; Ruggeri, P; Teti, D; Valenti, A; Venza, I; Venza, M | 1 |
Furumitsu, Y; Inaba, M; Matsui-Yuasa, I; Morii, H; Morishima, Y; Nishizawa, Y; Ochi, T; Otani, S; Yukioka, K; Yukioka, M | 1 |
Chen, WP; Gerner, EW; LaFleur, BJ; McLaren, CE; Meyskens, FL; Thompson, PA; Wertheim, BC; Zell, JA | 1 |
1 trial(s) available for putrescine and dinoprostone
Article | Year |
---|---|
Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma.
Topics: Adenoma; Aged; Anticarcinogenic Agents; Biomarkers, Pharmacological; Biopsy; Colonoscopy; Colorectal Neoplasms; Dinoprostone; Double-Blind Method; Drug Therapy, Combination; Eflornithine; Enzyme Inhibitors; Female; Humans; Intestinal Mucosa; Likelihood Functions; Logistic Models; Male; Middle Aged; Neoplasms, Second Primary; Polyamines; Putrescine; Rectum; Spermidine; Spermine; Sulindac; Time Factors; Treatment Outcome | 2010 |
5 other study(ies) available for putrescine and dinoprostone
Article | Year |
---|---|
Involvement of the ornithine decarboxylase pathway in macrophage collagenase production.
Topics: Animals; Bucladesine; Cells, Cultured; Dinoprostone; Eflornithine; Guinea Pigs; Indomethacin; Lipopolysaccharides; Macrophage Activation; Macrophages; Microbial Collagenase; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Prostaglandins E; Putrescine | 1988 |
Polyamine deprivation prevents the development of tumour-induced immune suppression.
Topics: Animals; Carcinoma, Lewis Lung; Dinoprostone; Eflornithine; Enzyme Inhibitors; Immune Tolerance; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Organ Size; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polyamines; Putrescine; Spleen; T-Lymphocytes | 1997 |
Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Cells, Cultured; Chagas Disease; Cysteine Proteinase Inhibitors; Dinoprostone; Macrophages; Male; Mice; Mice, Inbred BALB C; Necrosis; Phagocytosis; Putrescine; Receptors, Vitronectin; T-Lymphocytes; Transforming Growth Factor beta; Trypanosoma cruzi | 2000 |
Polyamine metabolism in prostaglandin E2-treated human T lymphocytes.
Topics: Acetyltransferases; Biogenic Polyamines; Cyclic AMP; Dinoprostone; Humans; In Vitro Techniques; Ornithine Decarboxylase; Putrescine; Spermidine; Spermine; T-Lymphocytes | 2000 |
Interleukin-1beta induces elevation of spermidine/spermine N1-acetyltransferase activity and an increase in the amount of putrescine in synovial adherent cells from patients with rheumatoid arthritis.
Topics: Acetyltransferases; Arthritis, Rheumatoid; Cell Division; Cells, Cultured; Collagenases; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression; Humans; Interleukin-1; Matrix Metalloproteinase 3; Putrescine; Spermidine; Spermine; Synovial Membrane | 2000 |